Old Web
English
Sign In
Acemap
>
authorDetail
>
Y. M. Mostafa Kamel
Y. M. Mostafa Kamel
Eltrombopag
Medicine
Pathology
Chemotherapy
Internal medicine
3
Papers
3
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Hepatobiliary (HB) safety of eltrombopag administered after carboplatin+paclitaxel (Carb+Pac) in patients (pts) with solid tumors
2016
Journal of Clinical Oncology
A. Kellum
A. Jagiello-Gruszfeld
I N Bondarenko
R. Rafi
P. Giangiulio
C. Messam
Y. M. Mostafa Kamel
Show All
Source
Cite
Save
Citations (1)
An open-label, dose-ranging study to assess the safety, efficacy, and pharmacokinetics of eltrombopag in treating thrombocytopenia in patients with advanced sarcomas receiving doxorubicin and ifosfamide.
2010
Journal of Clinical Oncology
Sant P. Chawla
Arthur P. Staddon
C. Messam
A. M. Graham
Y. M. Mostafa Kamel
Show All
Source
Cite
Save
Citations (1)
Thrombopoietin expression and effects of eltrombopag in prostate, breast, lung, and ovarian solid tumors.
2010
Journal of Clinical Oncology
Connie L. Erickson-Miller
Kodandaram Pillarisetti
Jennifer Kirchner
Lone H. Ottesen
Y. M. Mostafa Kamel
Yuan Liu
Anne-Marie Martin
C. Messam
Show All
Source
Cite
Save
Citations (1)
1